Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
Bills can add up fast when you're dealing with a health crisis. And if you can't pay them, they can wreak havoc on your finances. Here's how to stay out of medical debt — or make it go away.
-
First, they were struck by illness and then by medical bills they couldn't pay. Here are 15 stories of Americans living under the shadow of health care debt.
-
The state's program of free cancer screening and treatment is reducing inequities. Key to its success is robust outreach by patient navigators who connect with those least likely to seek care.
-
Mask mandates are going away around the country, so shops and restaurants are developing their own policies based on personal choice and risk tolerance.
-
For some people, getting a positive coronavirus test could mean loss of income or other life disruptions. Doctors worry about growing disincentives to test and how this could prolong the pandemic.
-
Amid a surge in omicron cases and hospitalizations, public health leaders are grappling with how to get a tuned-out public to pay attention. Experts urge communicators to cut through the noise.
-
A ban on using telemedicine to prescribe controlled medications was suspended in the pandemic. That's allowed many to seek opioid addiction treatment, but some worry about potential for abuse.
-
With a fast-growing winter surge upon us, self-testing kits remain expensive and hard to find. The reasons go back to the approach the U.S. took from the outset in developing tests.
-
State rules were temporarily loosened in 2020 to help patients get care outside a doctor's office. But is telehealth by phone safe and effective? State legislatures and insurers must soon decide.
-
Telehealth services were important during the pandemic. Rules that permitted its growth are in flux, as state and federal governments and insurance providers weigh which policies to keep in place.